{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T10:08:27Z","timestamp":1773137307217,"version":"3.50.1"},"reference-count":47,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,1,20]]},"abstract":"<jats:p>\n            <jats:italic>Aspergillus<\/jats:italic>\n            galactomannan antigenemia is an accepted tool for the diagnosis of invasive pulmonary aspergillosis (IPA) in neutropenic patients. Little is known, however, about the utility of this biomarker to assess the efficacy of antifungal therapies. The pharmacokinetics (PK) and pharmacodynamics (PD) of posaconazole in treatment and prophylaxis were investigated in the persistently neutropenic rabbit model of\n            <jats:named-content content-type=\"genus-species\">Aspergillus fumigatus<\/jats:named-content>\n            IPA at doses between 2 and 20\u2009mg\/kg per day.\n          <\/jats:p>","DOI":"10.1128\/aac.01574-20","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T14:20:35Z","timestamp":1604499635000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-6123","authenticated-orcid":false,"given":"Silke","family":"Gastine","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical and Medical Chemistry, Department of Clinical Pharmacy, Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster, M\u00fcnster, Germany"},{"name":"Infection, Immunity, and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6187-878X","authenticated-orcid":false,"given":"William","family":"Hope","sequence":"additional","affiliation":[{"name":"Centre of Excellence in Infectious Diseases Research, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Hempel","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical and Medical Chemistry, Department of Clinical Pharmacy, Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Petraitiene","sequence":"additional","affiliation":[{"name":"Transplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidmantas","family":"Petraitis","sequence":"additional","affiliation":[{"name":"Transplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Mickiene","sequence":"additional","affiliation":[{"name":"Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Bacher","sequence":"additional","affiliation":[{"name":"Surgery Service, Veterinary Resources Program, Office of Research Services, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Weill Cornell Medicine of Cornell University, New York, New York, USA"},{"name":"Department of Microbiology and Immunology, Weill Cornell Medicine of Cornell University, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology\/Oncology, University Children\u2019s Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.10.012"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2010.01984.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01306-y"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061094"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061098"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/508774"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1533"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212837"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03050-14"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02686-13"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv380"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx263"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw444"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.002"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky286"},{"key":"e_1_3_2_17_2","volume-title":"Noxafil: summary of product characteristics","author":"European Medicines Agency","year":"2009","unstructured":"European Medicines Agency. 2009. Noxafil: summary of product characteristics. European Medicines Agency, Amsterdam, Netherlands. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/noxafil-epar-product-information_en.pdf. Accessed 2 May 2020."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2006.06.007"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx029"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.64"},{"key":"e_1_3_2_21_2","volume-title":"Posaconazole: rationale for the EUCAST clinical breakpoints, version 2.0","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2017","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2017. Posaconazole: rationale for the EUCAST clinical breakpoints, version 2.0. European Committee on Antimicrobial Susceptibility Testing, V\u00e4xj\u00f6, Sweden. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Files\/Posaconazole_Yeast_Molds_RD_V.2_Apr__2017.pdf. Accessed 27 September 2018."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00931-09"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir023"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0437-7"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007394.pub2"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-017-9509-1"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2018.1488589"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir441"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/528714"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22863"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.857-869.2001"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03569-14"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903485056"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-016-0255-4"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.1.137-142.2004"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03850-14"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2006.01296.x"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.09.004"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004271402"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/524063"},{"key":"e_1_3_2_41_2","first-page":"385","volume-title":"Abstr 40th Intersci Conf Antimicrob Agents Chemother","author":"Groll AM","year":"2001","unstructured":"Groll AM, Petraitiene R, Petraitis V, Sein T, Piscitelli SC, Walsh TJ. 2001. Pharmacokinetics and pharmacodynamics of posaconazole (SCH 56592) in a neutropenic animal model of invasive pulmonary aspergillosis, abstr 1675, p 385. Abstr 40th Intersci Conf Antimicrob Agents Chemother. American Society for Microbiology, Washington, DC."},{"key":"e_1_3_2_42_2","first-page":"467","article-title":"Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits","volume":"38","author":"Walsh TJ","year":"1988","unstructured":"Walsh TJ, Bacher J, Pizzo PA. 1988. Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits. Lab Anim Sci 38:467\u2013471.","journal-title":"Lab Anim Sci"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.35.1.139-143.1997"},{"key":"e_1_3_2_44_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"National Committee for Clinical Laboratory Standards","year":"1997","unstructured":"National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.2.356"},{"key":"e_1_3_2_46_2","volume-title":"ADAPT II user\u2019s guide","author":"D\u2019Argenio DZ","year":"1990","unstructured":"D\u2019Argenio DZ, Schumitzky A. 1990. ADAPT II user\u2019s guide. Biomedical Simulations Resource. University of Southern California, Los Angeles, CA."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.727-731.2000"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31825c4ba6"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01574-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01574-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:51:15Z","timestamp":1645480275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01574-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,20]]}},"alternative-id":["10.1128\/AAC.01574-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01574-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"2020-07-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01574-20"}}